PETER JINDRA to Retrospective Studies
This is a "connection" page, showing publications PETER JINDRA has written about Retrospective Studies.
Connection Strength
0.158
-
Prognostic factors to predict outcome of reduced intensity allogeneic haematopoietic cell transplantation for chronic lymphocytic leukemia. Neoplasma. 2016; 63(4):595-600.
Score: 0.034
-
The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type: an analysis of 96 allografted AML patients = 50 years from the Czech acute leukaemia clinical register (alert). Neoplasma. 2013; 60(5):576-83.
Score: 0.028
-
Soluble mesothelin-related peptide as a prognosticator in pleural mesothelioma patients receiving checkpoint immunotherapy. J Thorac Cardiovasc Surg. 2025 Apr; 169(4):1082-1095.e4.
Score: 0.016
-
Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT. Bone Marrow Transplant. 2024 02; 59(2):224-231.
Score: 0.015
-
Rare variants and HLA haplotypes associated in patients with neuromyelitis optica spectrum disorders. Front Immunol. 2022; 13:900605.
Score: 0.014
-
Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT. Bone Marrow Transplant. 2021 03; 56(3):614-621.
Score: 0.012
-
Blastic plasmacytoid dendritic cell neoplasm: First retrospective study in the Czech Republic. Neoplasma. 2020 May; 67(3):650-659.
Score: 0.011
-
Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma. JCI Insight. 2018 04 05; 3(7).
Score: 0.010
-
Pediatric Liver Transplantation Across the ABO Blood Group Barrier: Is It an Obstacle in the Modern Era? J Am Coll Surg. 2016 Apr; 222(4):681-9.
Score: 0.009
-
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2014 Mar; 49(3):389-96.
Score: 0.007
-
Allogeneic BMT in patients above 45 years of age: a single center experience. Bone Marrow Transplant. 2001 Apr; 27(7):723-6.
Score: 0.003